Skip to search boxSkip to navigationSkip to main content

Impact of pathological features of brain metastases in prognosis

  • Carlos A. Castaneda(corresponding author)
    ,
  • Miluska Castillo
    ,
  • Luis A. Bernabe
    ,
  • Joselyn Sanchez
    ,
  • Sandro Casavilca
    ,
  • Pamela García-Corrochano
*Corresponding author for this work
  • ,
  • Universidad Privada San Juan Bautista
    ,
  • Instituto Nacional de Enfermedades Neoplásicas
Research Output:
Contribution to journal
Article
Peer-review

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 475-485 (11 pages)

Journal (Volume, Issue Number)

Biomarkers in Medicine (Volume 12, Issue 5)

Publication milestones

  • Published - 05/2018

Publication status

Published - 05/2018

ISSN

1752-0363

Publication IDs

  • Scopus: 85046846243
  • PubMed: 29697273

Abstract

Aim: To evaluate the prognostic value of tumor-infiltrating lymphocytes (TILs) and Ki67 in brain metastasis lesions, and the effect of adding them to variables of graded prognostic assessment score. Patients & methods: Clinicopathological information from 111 medical charts of brain metastasis patients was obtained, and TIL distribution (n = 84), Ki67 index (n = 79) and CD3 TIL (n = 64) were prospectively evaluated. Results: Most frequent TIL pattern was perivascular (67.8%), and median Ki67 and CD3 TIL percents were 30 and 4.8%, respectively. Ki67 ≥15 was associated with shorter survival (p = 0.018) but CD3 TIL was not (p = 0.870). The highest graded prognostic assessment score was not associated with survival (p = 0.648), however, those with low Ki67 and high score was associated with better outcome (p = 0.007). Conclusion: High Ki67 index in brain metastasis carries a worse prognosis.

Funding Details

This study was possible thanks to the use of the Automatic Multispectral Imaging System (Olympus BX63) financed by the Pro-grama Nacional de Innovación para la Competitividad y Productividad (Innovate Peru), under the contract 317-PNICP-EC-2014. The authors would like to express their gratitude to V Flores for his support in staining preparation of tumor sections; and to C Flores for a biostatistics review. Informed consent was obtained from each study participant. This study was reviewed and approved by the Instituto Nacional de Enfermedades Neoplasicas Institutional Review Board.
FundersFunding numbers
Instituto Nacional de Enfermedades Neoplasicas Institutional Review Board
-
Pro-grama Nacional de Innovación para la Competitividad y Productividad
317-PNICP-EC-2014
Olympus
-